Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy

Suk Ho Byeon, Young Ju Lew, Sung Chul Lee, Oh Woong Kwon

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: To report on the clinical course of pulsating polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). Methods: A total of 63 eyes of 58 consecutive patients diagnosed with PCV, treated with PDT and followed up for at least 6 months were enrolled. Best-corrected visual acuity (BCVA), fluorescein angiography and high-speed indocyanine green angiography (ICGA) using confocal scanning laser ophthalmoscopy (HRA) were performed. Results: Of the 63 PCV eyes, 14 eyes (22.2%) of 14 patients were classified as having pulsating PCV. The mean age of pulsating PCV patients was 60.6 ± 7.0 years (48-69 years), which was younger than non-pulsating PCV patients (65.7 years, p = 0.035). The mean follow-up period was 23.9 ± 10.7 months, and PDT was administered 1.6 ± 0.9 times to pulsating PCV patients. The mean logMAR BCVAs were 0.85 ± 0.47 at presentation and 0.71 ± 0.52 at final examination. Extensive haemorrhagic events were more common in pulsating than in non-pulsating PCV patients (57.1% versus 26.5%, p = 0.032). However, the risk of haemorrhage within 3 months of PDT was similar for both pulsating PCV and the remaining patients (14.3% versus 20%, p = 0.723). Conclusion: Pulsating PCV showed distinctive features including a relatively younger patient age at presentation, and a haemorrhagic tendency (especially extensive). However, the use of PDT did not directly increase the risk of haemorrhage in pulsating PCV patients.

Original languageEnglish
Pages (from-to)660-668
Number of pages9
JournalActa Ophthalmologica
Volume88
Issue number6
DOIs
Publication statusPublished - 2010 Sep 1

Fingerprint

Photochemotherapy
Hemorrhage
Ophthalmoscopy
Indocyanine Green
Fluorescein Angiography
Visual Acuity
Angiography
Lasers

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

@article{8c3ce2c538454347ad5e9f5c3c531ff5,
title = "Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy",
abstract = "Purpose: To report on the clinical course of pulsating polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). Methods: A total of 63 eyes of 58 consecutive patients diagnosed with PCV, treated with PDT and followed up for at least 6 months were enrolled. Best-corrected visual acuity (BCVA), fluorescein angiography and high-speed indocyanine green angiography (ICGA) using confocal scanning laser ophthalmoscopy (HRA) were performed. Results: Of the 63 PCV eyes, 14 eyes (22.2{\%}) of 14 patients were classified as having pulsating PCV. The mean age of pulsating PCV patients was 60.6 ± 7.0 years (48-69 years), which was younger than non-pulsating PCV patients (65.7 years, p = 0.035). The mean follow-up period was 23.9 ± 10.7 months, and PDT was administered 1.6 ± 0.9 times to pulsating PCV patients. The mean logMAR BCVAs were 0.85 ± 0.47 at presentation and 0.71 ± 0.52 at final examination. Extensive haemorrhagic events were more common in pulsating than in non-pulsating PCV patients (57.1{\%} versus 26.5{\%}, p = 0.032). However, the risk of haemorrhage within 3 months of PDT was similar for both pulsating PCV and the remaining patients (14.3{\%} versus 20{\%}, p = 0.723). Conclusion: Pulsating PCV showed distinctive features including a relatively younger patient age at presentation, and a haemorrhagic tendency (especially extensive). However, the use of PDT did not directly increase the risk of haemorrhage in pulsating PCV patients.",
author = "Byeon, {Suk Ho} and Lew, {Young Ju} and Lee, {Sung Chul} and Kwon, {Oh Woong}",
year = "2010",
month = "9",
day = "1",
doi = "10.1111/j.1755-3768.2009.01517.x",
language = "English",
volume = "88",
pages = "660--668",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "Wiley-Blackwell",
number = "6",

}

Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. / Byeon, Suk Ho; Lew, Young Ju; Lee, Sung Chul; Kwon, Oh Woong.

In: Acta Ophthalmologica, Vol. 88, No. 6, 01.09.2010, p. 660-668.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy

AU - Byeon, Suk Ho

AU - Lew, Young Ju

AU - Lee, Sung Chul

AU - Kwon, Oh Woong

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Purpose: To report on the clinical course of pulsating polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). Methods: A total of 63 eyes of 58 consecutive patients diagnosed with PCV, treated with PDT and followed up for at least 6 months were enrolled. Best-corrected visual acuity (BCVA), fluorescein angiography and high-speed indocyanine green angiography (ICGA) using confocal scanning laser ophthalmoscopy (HRA) were performed. Results: Of the 63 PCV eyes, 14 eyes (22.2%) of 14 patients were classified as having pulsating PCV. The mean age of pulsating PCV patients was 60.6 ± 7.0 years (48-69 years), which was younger than non-pulsating PCV patients (65.7 years, p = 0.035). The mean follow-up period was 23.9 ± 10.7 months, and PDT was administered 1.6 ± 0.9 times to pulsating PCV patients. The mean logMAR BCVAs were 0.85 ± 0.47 at presentation and 0.71 ± 0.52 at final examination. Extensive haemorrhagic events were more common in pulsating than in non-pulsating PCV patients (57.1% versus 26.5%, p = 0.032). However, the risk of haemorrhage within 3 months of PDT was similar for both pulsating PCV and the remaining patients (14.3% versus 20%, p = 0.723). Conclusion: Pulsating PCV showed distinctive features including a relatively younger patient age at presentation, and a haemorrhagic tendency (especially extensive). However, the use of PDT did not directly increase the risk of haemorrhage in pulsating PCV patients.

AB - Purpose: To report on the clinical course of pulsating polypoidal choroidal vasculopathy (PCV) treated with photodynamic therapy (PDT). Methods: A total of 63 eyes of 58 consecutive patients diagnosed with PCV, treated with PDT and followed up for at least 6 months were enrolled. Best-corrected visual acuity (BCVA), fluorescein angiography and high-speed indocyanine green angiography (ICGA) using confocal scanning laser ophthalmoscopy (HRA) were performed. Results: Of the 63 PCV eyes, 14 eyes (22.2%) of 14 patients were classified as having pulsating PCV. The mean age of pulsating PCV patients was 60.6 ± 7.0 years (48-69 years), which was younger than non-pulsating PCV patients (65.7 years, p = 0.035). The mean follow-up period was 23.9 ± 10.7 months, and PDT was administered 1.6 ± 0.9 times to pulsating PCV patients. The mean logMAR BCVAs were 0.85 ± 0.47 at presentation and 0.71 ± 0.52 at final examination. Extensive haemorrhagic events were more common in pulsating than in non-pulsating PCV patients (57.1% versus 26.5%, p = 0.032). However, the risk of haemorrhage within 3 months of PDT was similar for both pulsating PCV and the remaining patients (14.3% versus 20%, p = 0.723). Conclusion: Pulsating PCV showed distinctive features including a relatively younger patient age at presentation, and a haemorrhagic tendency (especially extensive). However, the use of PDT did not directly increase the risk of haemorrhage in pulsating PCV patients.

UR - http://www.scopus.com/inward/record.url?scp=77956204111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956204111&partnerID=8YFLogxK

U2 - 10.1111/j.1755-3768.2009.01517.x

DO - 10.1111/j.1755-3768.2009.01517.x

M3 - Article

C2 - 19563374

AN - SCOPUS:77956204111

VL - 88

SP - 660

EP - 668

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

IS - 6

ER -